Partial correlation corrected for age, BMI, liver steatosis, diabetes and LDL revealed significant associations of serum PCSK9 with the MELD score (r = −0.395, p = 0.031), bilirubin (r = −0.372, p = 0.043), leukocyte count (r = 0.521, p = 0.003) and CRP (r = −0.459, p = 0.011). Here, PCSK9 is linked to fatty liver disease.